News

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated ...
Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced ...
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 18, 2025 /PRNewswire/ -- USA ...
Individuals with metabolic dysfunction‐associated steatotic liver disease experience a higher burden of multimorbidity, with ...
The company is positioning BE-Smart for near-term commercialization, targeting the $10 billion esophageal disease testing ...
Sana Makbul reveals her battle with liver cirrhosis, stemming from an autoimmune disorder diagnosed after initial signs in ...